OrthoPediatrics Announces Full Commercial Launch of VerteGlide® Spinal Growth Guidance System
OrthoPediatrics Announces Full Commercial Launch Of Its VerteGlide Spinal Growth Guidance System
OrthoPediatrics to Participate in Upcoming Conferences
All You Need to Know About OrthoPediatrics (KIDS) Rating Upgrade to Buy
OrthoPediatrics (KIDS) Stock Sees Fair Value Lift After Higher Growth And New Product Wins
Lake Street Maintains Buy on OrthoPediatrics, Raises Price Target to $38
OrthoPediatrics: Q3 Earnings Snapshot
Canaccord Genuity Maintains Buy on OrthoPediatrics, Raises Price Target to $30
Truist Securities Maintains Hold on OrthoPediatrics, Raises Price Target to $28
TD Cowen Maintains Buy on OrthoPediatrics, Raises Price Target to $28
Stifel Maintains Buy on OrthoPediatrics, Raises Price Target to $27
OrthoPediatrics Corp. Q3 2026 Earnings Call Summary
Piper Sandler Reiterates Overweight on OrthoPediatrics, Raises Price Target to $30
BTIG Maintains Buy on OrthoPediatrics, Raises Price Target to $30
OrthoPediatrics: 3 Key Takeaways for Long-Term Investors
OrthoPediatrics Q3 Earnings Call Highlights
OrthoPediatrics Corp. (KIDS) Q3 2026 Earnings Call Transcript
OrthoPediatrics (KIDS) Q3 2026 Earnings Call Transcript
OrthoPediatrics Announces FDA 510(k) Clearance of PNP | Femur Retrograde Nail System and Completes First Implantations
OrthoPediatrics Corp. Reports Third Quarter 2026 Financial Results and Increases 2026 Financial Guidance
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.